NEWS RELEASES

LEXSTON LIFE SCIENCES CORP. ANNOUNCES LISTING OF ITS COMMON SHARES ON THE CANADIAN SECURITIES EXCHANGE

Vancouver, British Columbia, JUNE 23, 2021. Lexston Life Sciences Corp. (the “Company”) is pleased to announce that its common shares will commence trading at market open on June 25, 2021 on the Canadian Securities Exchange under the stock symbol “LEXT”. The Company has a total of 49,968,260 common shares, 2,000,000 options and 18,843,260 warrants issued and outstanding.

About Lexston Life Sciences Corp.

Lexston Life Sciences Corp. (“Lexston”) is a Canadian biotechnology company providing cannabis testing and research services. Lexston is also in the process of securing licensing under the exemptions prescribed by section 56 of the Controlled Drugs and Substances Act (Canada) to enable the expansion of prescribed by section 56 of the Controlled Drugs and Substances Act (Canada) to enable the expansion of psychedelic molecules in the lab and point of care. Lexston intends to develop and validate methods for standardized manufacturing of plant derived psychedelics in support of burgeoning trials in the field of mental health and wellness.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal
Chief Executive Officer
Telephone: (604) 928-8913

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

929 Mainland Street Vancouver, BC V6B 1S3

Phone: (604) 928-8913

Fax: (604) 628-0129

Email: [email protected]

Website: www.lexston.ca

Menu